Investigation of Label Information on Over-the-Counter Medicines
10.11256/jjdi.11.16
- VernacularTitle:一般用医薬品の外箱情報の記載状況に関する調査
- Author:
Masayuki Hashiguchi
;
Ai Aoki
;
Takashi Usami
;
Mayumi Mochizuki
- Publication Type:Journal Article
- Keywords:
label information;
over-the-counter medicine;
description item;
description method;
common cold remedy
- From:Japanese Journal of Drug Informatics
2009;11(1):16-23
- CountryJapan
- Language:Japanese
-
Abstract:
Objective : To determine how much label information on over-the-counter (OTC) medicines is contained on packaging, we investigated the items, description methods, and area of label information on packages.
Methods : We selected 75 common cold remedy products for investigation and classified the items into 3 categories (“items for use”, “items with a regulation requirement”, “items related to product image”) and measured the space given to each item in the total package area.
Results : All 75 products had “items with a regulation requirement (total 13 items),” but 8 products (only 2 manufacturers) had “consult a physician or pharmacist before use,” which was not a regulation requirement. There were differences in description methods, especially in “caution” and “product name.” Sixty percent of the OTC products used non-red characters with no box-frame, and 11% used red characters and box-frames. The description order was not standardized, but “caution” was located in the lowest space on 80% of products. Many item descriptions appeared in one place, but “product name” generally appeared in more than 4 places. While 4.5 to 8.0 points were commonly given for “items for use,” 16 to 100 points were given for “product name,” and the difference in number of points was greater than 6-fold among products. The percentage of average area for “items related to product image” (6.1%) was 2-fold greater than for “items for use” (3.1%) and “items with a regulation requirement” (2.9%). Almost half of the total package area was blank space.
Conclusion : Current descriptions in label information vary among items, products, and pharmaceutical companies. Rules on describing information on OTC medicine packaging are thus necessary.
